Skip to main content

Table 2 Early results of the unmatched and matched cohort

From: Revascularization outcomes in diabetic patients presenting with acute coronary syndrome with non-ST elevation

 

Before matching

After matching

PCI

N = 1652 (%)

CABG

N = 335 (%)

p-value

PCI

N = 200 (%)

CABG

N = 200 (%)

p-value

30-day outcomes

 Mortality

35 (2.1)

11 (3.3)

0.272

6 (3)

4 (2)

0.755

 Recurrent MI

47 (3.0)

2 (0.7)

0.031

12 (6)

1 (0.5)

0.005

 Stent thrombosis

9 (0.7)

–

–

0 (0)

–

–

 CVA

10 (0.6)

0 (0)

0.315

4 (2)

0 (0)

0.132

 MACEa

89 (7.1)

14 (6.1)

0.704

18 (10.6)

5 (3)

0.011

1-year mortality

125 (7.6)

32 (9.6)

0.264

16 (8)

19 (9.6)

0.712

  1. CABG, Coronary artery bypass graft; PCI, Percutaneous coronary intervention; MI, Myocardial infarction; CVA, Cerebrovascular accident; MACE, Major adverse cardiac events
  2. aMACE is defined as mortality, recurrent MI or stroke at 30 days
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840